Craft

Boule Diagnostics

Stock Price

KR7.2

2024-10-29

Market Capitalization

KR279.6 M

2024-10-29

Revenue

KR489.7 M

FY, 2025

Boule Diagnostics Summary

Company Summary

Overview
Boule Diagnostics is a healthcare technology company that develops, manufactures, and sells medical devices for blood analysis. It offers hematology analyzers, reagents, and controls. The company serves small and medium-sized patient care environments in both human and veterinary diagnostic markets.
Type
Public
Status
Active
Founded
1992
HQ
Spånga, SE | view all locations
Website
https://www.boule.com/en/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Christina Rubenhag

    Christina Rubenhag, Acting CEO and Group President

    LocationsView all

    3 locations detected

    • Spånga, Stockholms län HQ

      Sweden

      4 Domnarvsgatan

    • Plantation, FL

      United States

      1800 NW 65th Ave

    • Moskva

      Russian Federation

      4-Y Lesnoy Pereulok

    Boule Diagnostics Financials

    Summary Financials

    Revenue (Q1, 2026)
    kr101.6M
    Gross profit (Q1, 2026)
    kr48.0M
    Net income (Q1, 2026)
    (kr14.6M)
    Cash (Q1, 2026)
    kr18.5M
    EBIT (Q1, 2026)
    (kr1.4M)
    Enterprise value
    $426.4M

    Footer menu